Merck Share Holder Equity 1986-2025 | MRK

Merck share holder equity from 1986 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
  • Merck share holder equity for the quarter ending June 30, 2025 was $49.060B, a 12.4% increase year-over-year.
  • Merck share holder equity for 2024 was $46.372B, a 23.22% increase from 2023.
  • Merck share holder equity for 2023 was $37.635B, a 18.29% decline from 2022.
  • Merck share holder equity for 2022 was $46.058B, a 20.39% increase from 2021.
Merck Annual Share Holder Equity
(Millions of US $)
2024 $46,372
2023 $37,635
2022 $46,058
2021 $38,257
2020 $25,404
2019 $26,001
2018 $26,882
2017 $34,569
2016 $40,308
2015 $44,767
2014 $48,791
2013 $52,326
2012 $55,463
2011 $56,943
2010 $56,805
2009 $61,485
2008 $21,167
2007 $18,185
2006 $17,560
2005 $17,978
2004 $17,288
2003 $15,576
2002 $18,201
2001 $16,050
2000 $14,832
1999 $13,242
1998 $12,802
1997 $12,614
1996 $11,971
1995 $11,736
1994 $11,139
1993 $10,022
1992 $5,003
1991 $4,916
1990 $3,834
1989 $3,521
1988 $2,856
1987 $2,117
1986 $2,541
1985 $2,634
Merck Quarterly Share Holder Equity
(Millions of US $)
2025-06-30 $49,060
2025-03-31 $48,400
2024-12-31 $46,372
2024-09-30 $44,560
2024-06-30 $43,648
2024-03-31 $40,424
2023-12-31 $37,635
2023-09-30 $41,300
2023-06-30 $38,742
2023-03-31 $46,905
2022-12-31 $46,058
2022-09-30 $44,524
2022-06-30 $43,318
2022-03-31 $40,953
2021-12-31 $38,257
2021-09-30 $35,863
2021-06-30 $33,388
2021-03-31 $27,039
2020-12-31 $25,404
2020-09-30 $29,270
2020-06-30 $27,744
2020-03-31 $26,300
2019-12-31 $26,001
2019-09-30 $26,925
2019-06-30 $27,737
2019-03-31 $27,670
2018-12-31 $26,882
2018-09-30 $32,656
2018-06-30 $32,766
2018-03-31 $33,901
2017-12-31 $34,569
2017-09-30 $38,499
2017-06-30 $39,712
2017-03-31 $40,088
2016-12-31 $40,308
2016-09-30 $43,957
2016-06-30 $43,446
2016-03-31 $43,901
2015-12-31 $44,767
2015-09-30 $45,679
2015-06-30 $46,638
2015-03-31 $47,917
2014-12-31 $48,791
2014-09-30 $45,360
2014-06-30 $48,516
2014-03-31 $52,564
2013-12-31 $52,326
2013-09-30 $50,006
2013-06-30 $50,105
2013-03-31 $55,606
2012-12-31 $55,463
2012-09-30 $58,212
2012-06-30 $57,673
2012-03-31 $57,314
2011-12-31 $56,943
2011-09-30 $57,596
2011-06-30 $57,922
2011-03-31 $56,839
2010-12-31 $56,805
2010-09-30 $58,048
2010-06-30 $57,666
2010-03-31 $60,343
2009-12-31 $61,485
2009-09-30 $25,349
2009-06-30 $22,737
2009-03-31 $22,002
2008-12-31 $21,167
2008-09-30 $19,571
2008-06-30 $20,256
2008-03-31 $19,522
2007-12-31 $18,185
2007-09-30 $20,722
2007-06-30 $19,472
2007-03-31 $18,479
2006-12-31 $17,560
2006-09-30 $19,285
2006-06-30 $19,299
2006-03-31 $18,846
2005-12-31 $17,978
2005-09-30 $17,778
2005-06-30 $17,385
2005-03-31 $17,649
2004-12-31 $17,288
2004-09-30 $17,312
2004-06-30 $16,967
2004-03-31 $16,271
2003-12-31 $15,576
2003-09-30 $15,313
2003-06-30 $19,607
2003-03-31 $18,876
2002-12-31 $18,201
2002-09-30 $17,533
2002-06-30 $16,777
2002-03-31 $16,446
2001-12-31 $16,050
2001-09-30 $15,357
2001-06-30 $14,766
2001-03-31 $14,857
2000-12-31 $14,832
2000-09-30 $13,520
2000-06-30 $12,719
2000-03-31 $12,102
1999-12-31 $13,242
1999-09-30 $12,857
1999-06-30 $12,975
1999-03-31 $13,343
1998-12-31 $12,802
1998-09-30 $12,561
1998-06-30 $13,664
1998-03-31 $13,146
1997-12-31 $12,614
1997-09-30 $12,834
1997-06-30 $12,821
1997-03-31 $12,432
1996-12-31 $11,971
1996-09-30 $11,397
1996-06-30 $11,333
1996-03-31 $11,663
1995-12-31 $11,736
1995-09-30 $11,517
1995-06-30 $11,361
1995-03-31 $11,048
1994-12-31 $11,139
1994-09-30 $11,257
1994-06-30 $10,870
1994-03-31 $10,415
1993-12-31 $10,022
1993-09-30 $5,266
1993-06-30 $4,928
1993-03-31 $5,172
1992-12-31 $5,003
1992-09-30 $5,474
1992-06-30 $5,313
1992-03-31 $5,114
1991-12-31 $4,916
1991-09-30 $4,649
1991-06-30 $4,365
1991-03-31 $4,057
1990-12-31 $3,834
1990-09-30 $3,733
1990-06-30 $3,686
1990-03-31 $3,494
1989-12-31 $3,521
1989-09-30 $3,335
1989-06-30 $3,136
1989-03-31 $3,045
1988-12-31 $2,856
1988-09-30 $2,668
1988-06-30 $2,490
1988-03-31 $2,282
1987-12-31 $2,117
1987-09-30 $2,890
1987-06-30 $2,871
1987-03-31 $2,706
1986-12-31 $2,541
1985-12-31 $2,634
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $270.018B $59.283B
Merck & Co. boasts more than six blockbuster drugs in its portfolio with PD-L1 inhibitor, Keytruda, approved for several types of cancer. Keytruda has played an instrumental role in driving Merck's steady revenue growth in the past few years. Well-known products in Merck's portfolio include Keytruda, Simponi , Januvia and Janumet, Bridion, Isentress, ProQuad, Gardasil, Pneumovax 23, RotaTeq and Belsomra. Merck made its biggest acquisition of Schering-Plough and sold off its Consumer Care business to Bayer. Other key acquisitions include Idenix Pharmaceuticals, Cubist Pharmaceuticals, Rigontec, ArQule and Acceleron Pharma. IMerck spun off products from its Women's Health unit, legacy drugs and biosimilar products into a new publicly traded company called Organon & Co.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $495.141B 66.87
Johnson & Johnson (JNJ) United States $450.090B 16.68
Novo Nordisk (NVO) Denmark $424.453B 49.78
AbbVie (ABBV) United States $264.086B 11.85
AstraZeneca (AZN) United Kingdom $218.471B 19.74
Novartis AG (NVS) Switzerland $218.425B 15.54
Pfizer (PFE) United States $201.199B 7.39
Sanofi (SNY) $132.955B 11.89
Innoviva (INVA) United States $0.953B 10.12